| scholarly article | Q13442814 |
| P50 | author | Françoise Dignat-George | Q61874319 |
| P2093 | author name string | H Roger Lijnen | |
| Romaric Lacroix | |||
| Tiphaine Dejouvencel | |||
| Loïc Doeuvre | |||
| Eduardo Anglés-Cano | |||
| Laurent Plawinski | |||
| P2860 | cites work | Protease nexin-1 inhibits plasminogen activation-induced apoptosis of adherent cells | Q24303595 |
| Characterization of the gene for human plasminogen, a key proenzyme in the fibrinolytic system | Q28647031 | ||
| Extracellular proteolysis in the adult murine brain | Q34170437 | ||
| Regulation of plasminogen receptors | Q35011191 | ||
| Urokinase-type plasminogen activator is induced in migrating capillary endothelial cells | Q36217171 | ||
| Expression of the activation marker urokinase plasminogen-activator receptor in cultured human central nervous system microglia | Q36827290 | ||
| Plasminogen interacts with human platelets through two distinct mechanisms | Q36994814 | ||
| Monocyte urokinase-type plasminogen activator up-regulation reduces thrombus size in a model of venous thrombosis. | Q37424686 | ||
| Molecular mechanism of physiological fibrinolysis | Q39861594 | ||
| Activation of plasminogen into plasmin at the surface of endothelial microparticles: a mechanism that modulates angiogenic properties of endothelial progenitor cells in vitro | Q40112496 | ||
| The cell biology of the plasminogen system. | Q40447481 | ||
| Interaction of endothelial microparticles with monocytic cells in vitro induces tissue factor-dependent procoagulant activity | Q40732139 | ||
| In vitro generation of endothelial microparticles and possible prothrombotic activity in patients with lupus anticoagulant. | Q40851071 | ||
| Immobilisation of monocytes to a solid support: a model for the study of ligand-binding interactions and plasminogen activation at the cell surface. | Q40906597 | ||
| Expression of the receptor for urokinase-type plasminogen activator in normal and neoplastic blood cells and hematopoietic tissue | Q41011037 | ||
| Mechanism of the enhanced intrinsic activity of single-chain urokinase-type plasminogen activator during ongoing fibrinolysis. | Q41528496 | ||
| HMEC-1: establishment of an immortalized human microvascular endothelial cell line | Q41592068 | ||
| The THP-1 cell line is a urokinase-secreting mononuclear phagocyte with a novel defect in the production of plasminogen activator inhibitor-2. | Q41741597 | ||
| Evidence that the conformation of unliganded human plasminogen is maintained via an intramolecular interaction between the lysine-binding site of kringle 5 and the N-terminal peptide | Q42159197 | ||
| Role of plasminogen activation in neuronal organization and survival | Q43291323 | ||
| The importance of the preactivation peptide in the two-stage mechanism of human plasminogen activation | Q43510374 | ||
| Comparison of some properties of native (Glu) and modified (Lys) human plasminogen | Q43554848 | ||
| Expression of recombinant human plasminogen in mammalian cells is augmented by suppression of plasmin activity | Q44163167 | ||
| Pericellular plasmin induces smooth muscle cell anoikis. | Q44435291 | ||
| Structural and functional characterization of mutants of recombinant single-chain urokinase-type plasminogen activator obtained by site-specific mutagenesis of Lys158, Ile159 and Ile160. | Q44449750 | ||
| Plasminogen interactions with platelets in plasma | Q45076257 | ||
| Functional hierarchy of plasminogen kringles 1 and 4 in fibrinolysis and plasmin-induced cell detachment and apoptosis | Q46566135 | ||
| Depolarization and neurotransmitters increase neuronal protein tyrosine phosphorylation | Q48171282 | ||
| Interactions of plasminogen with polymerizing fibrin and its derivatives, monitored with a photoaffinity cross-linker and electron microscopy | Q52219092 | ||
| Kinetics and mechanism of platelet-surface plasminogen activation by tissue-type plasminogen activator | Q52379808 | ||
| Characterization of the binding of plasminogen to fibrin surfaces: the role of carboxy-terminal lysines | Q52422835 | ||
| Cellular Origins and Thrombogenic Activity of Microparticles Isolated From Human Atherosclerotic Plaques | Q58149183 | ||
| Characterization of an extremely large, ligand-induced conformational change in plasminogen | Q67281216 | ||
| The effect of alpha-,omega-amino acids on human plasminogen structure and activation | Q67355696 | ||
| Studies on the conformational changes of plasminogen induced during activation to plasmin and by 6-aminohexanoic acid | Q68521774 | ||
| Physico-chemical and proenzyme properties of NH2-terminal glutamic acid and NH2-terminal lysine human plasminogen. Influence of 6-aminohexanoic acid | Q68528955 | ||
| Rate of activation and electrophoretic mobility of unmodified and partially degraded plasminogen. Effects of 6-aminohexanoic acid and related compounds | Q68535696 | ||
| Binding and activation of plasminogen on the platelet surface | Q69940744 | ||
| Production of monoclonal antibodies to the high fibrin-affinity, tissue-type plasminogen activator of human plasma. Demonstration of its endothelial origin by immunolocalization | Q69963426 | ||
| Binding of plasminogen to extracellular matrix | Q70299467 | ||
| Lysine/fibrin binding sites of kringles modeled after the structure of kringle 1 of prothrombin | Q70397716 | ||
| Sodium dodecyl sulfate-induced dissociation of complexes between human tissue plasminogen activator and its specific inhibitor | Q70745319 | ||
| The binding of human plasminogen to fibrin and fibrinogen | Q71687932 | ||
| Plasminogen, plasminogen activator, and platelets in the regulation of clot lysis. Reconstitution and patient studies | Q71842137 | ||
| Positive regulation of activation of plasminogen by urokinase: differences in Km for (glutamic acid)-plasminogen and lysine-plasminogen and effect of certain alpha, omega-amino acids | Q72758058 | ||
| Initial plasmin-degradation of fibrin as the basis of a positive feed-back mechanism in fibrinolysis | Q72815075 | ||
| Molecular assembly of plasminogen and tissue-type plasminogen activator on an evolving fibrin surface | Q72930376 | ||
| Failure of thrombus to resolve in urokinase-type plasminogen activator gene-knockout mice: rescue by normal bone marrow-derived cells | Q73013976 | ||
| Plasmin and matrix metalloproteinases in vascular remodeling | Q74314953 | ||
| P433 | issue | 10 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 2048-2056 | |
| P577 | publication date | 2009-12-07 | |
| P1433 | published in | Blood | Q885070 |
| P1476 | title | Fibrinolytic cross-talk: a new mechanism for plasmin formation | |
| P478 | volume | 115 |
| Q59400009 | A local uPAR-plasmin-TGFβ1 positive feedback loop in a qualitative computational model of angiogenic sprouting explains the in vitro effect of fibrinogen variants |
| Q90403197 | A new assay to evaluate microvesicle plasmin generation capacity: validation in disease with fibrinolysis imbalance |
| Q88645478 | Analysis of the thrombotic and fibrinolytic activities of tumor cell-derived extracellular vesicles |
| Q38543323 | Basic mechanisms and regulation of fibrinolysis |
| Q37821168 | Cellular Mechanisms Underlying the Formation of Circulating Microparticles |
| Q37892456 | Circulating microparticles: new insights into the biochemical basis of microparticle release and activity. |
| Q27678773 | Crystal structure of the native plasminogen reveals an activation‐resistant compact conformation |
| Q28488062 | Discrepant fibrinolytic response in plasma and whole blood during experimental endotoxemia in healthy volunteers |
| Q39405161 | Distant Space Processing is Controlled by tPA-dependent NMDA Receptor Signaling in the Entorhinal Cortex. |
| Q33789283 | Dysfunction of annexin A2 contributes to hyperglycaemia-induced loss of human endothelial cell surface fibrinolytic activity |
| Q48591118 | Effects of addition of tissue-type plasminogen activator in in vitro fertilization medium on bovine embryo development and quality |
| Q35939755 | Fibrinogen counteracts the antiadhesive effect of fibrin‐bound plasminogen by preventing its activation by adherent U937 monocytic cells |
| Q33401969 | Leukocyte- and endothelial-derived microparticles: a circulating source for fibrinolysis |
| Q43111392 | Membrane microvesicles: a circulating source for fibrinolysis, new antithrombotic messengers. |
| Q38874997 | Microparticles as biomarkers of venous thromboembolic events |
| Q38102452 | Microparticles in atrial fibrillation: A link between cell activation or apoptosis, tissue remodelling and thrombogenicity |
| Q37922118 | Microparticles: a critical component in the nexus between inflammation, immunity, and thrombosis |
| Q35164287 | Monoclonal antibodies detect receptor-induced binding sites in Glu-plasminogen |
| Q27300845 | Nano-zymography Using Laser-Scanning Confocal Microscopy Unmasks Proteolytic Activity of Cell-Derived Microparticles |
| Q26798032 | New Insight on the Role of Plasminogen Receptor in Cancer Progression |
| Q33768031 | New insights into the role of Plg-RKT in macrophage recruitment |
| Q41851432 | Phosphatidylserine as an anchor for plasminogen and its plasminogen receptor, Histone H2B, to the macrophage surface |
| Q45881345 | Plasma tissue-type plasminogen activator increases fibrinolytic activity of exogenous urokinase-type plasminogen activator |
| Q35071778 | Plasmin on adherent cells: from microvesiculation to apoptosis |
| Q37609916 | Plasminogen Receptors: The First Quarter Century |
| Q35450594 | Plasminogen associates with phosphatidylserine-exposing platelets and contributes to thrombus lysis under flow |
| Q42137305 | Reduced plasminogen binding and delayed activation render γ'-fibrin more resistant to lysis than γA-fibrin |
| Q38117725 | Revisited role of microparticles in arterial and venous thrombosis. |
| Q36343743 | So many plasminogen receptors: why? |
| Q38902224 | The Association of Plasminogen Activator Inhibitor Type 1 (PAI-1) Level and PAI-1 4G/5G Gene Polymorphism with the Formation and the Grade of Endometrial Cancer |
| Q36310829 | The duplication mutation of Quebec platelet disorder dysregulates PLAU, but not C10orf55, selectively increasing production of normal PLAU transcripts by megakaryocytes but not granulocytes |
| Q48465547 | Tissue-factor-bearing microparticles (MPs-TF) in patients with acute ischaemic stroke: the influence of stroke treatment on MPs-TF generation. |
| Q34429408 | Trauma-Induced Coagulopathy: An Institution's 35 Year Perspective on Practice and Research |
| Q52694337 | Use of microfluidics to assess the platelet-based control of coagulation |
| Q89581517 | uPA-mediated plasminogen activation is enhanced by polyphosphate |
Search more.